Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Health crawled date : 2020 - 12 - 07 save search
Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event
Published: 2020-12-07 (Crawled : 23:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M
|
Health Services
|
| O: 1.9%
H: 2.05%
C: 1.65%
health
uniQure Announces Two-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
Published: 2020-12-07 (Crawled : 21:06) - globenewswire.com
QURE | $4.71 0.86% 0.85% 440K
|
Health Technology
|
| O: 2.09%
H: 1.15%
C: -1.53%
Harpoon Therapeutics to Host Clinical Pipeline Programs Update Call and Webcast on December 8, 2020
Published: 2020-12-07 (Crawled : 21:06) - globenewswire.com
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 3.22%
H: 5.3%
C: -0.87%
program
Kymera Therapeutics Presents Preclinical Data on IRAKIMiD and STAT3 Programs at Virtual 62nd American Society of Hematology (ASH) Annual Meeting
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
KYMR | $35.16 4.15% 3.98% 620K
|
Health Technology
|
| O: 1.31%
H: 1.98%
C: -8.25%
preclinical pre-clinical
BridgeBio Pharma and Maze Therapeutics Establish Joint Venture to Advance Precision Medicine to Treat Cardiovascular Disease
Published: 2020-12-07 (Crawled : 14:02) - globenewswire.com
BBIO | $24.98 0.0% 2M
|
Health Technology
|
| O: 0.29%
H: 2.37%
C: 1.45%
disease cardio cardiovascular pharma
Sarepta Therapeutics Announces Positive Clinical Results from MOMENTUM, a Phase 2 Clinical Trial of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51
Published: 2020-12-07 (Crawled : 14:00) - globenewswire.com
SRPT | $116.59 -1.1% -1.12% 500K
|
Health Technology
|
| O: -1.99%
H: 1.94%
C: -2.54%
positive results trial phase 2 duchenne
Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin
Published: 2020-12-07 (Crawled : 13:06) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -1.71%
H: 3.61%
C: -9.4%
license commercialization health
Oncternal Therapeutics Announces Presentation of Interim Phase 1/2 Data Update for Cirmtuzumab in Combination with Ibrutinib at ASH 2020 Virtual Annual Meeting
Published: 2020-12-07 (Crawled : 13:02) - globenewswire.com
ONCT P | $8.79 -1.79% -1.82% 2.8K
|
Health Technology
|
| O: 48.5%
H: 23.29%
C: 0.76%
phase 3 phase 1 phase 2
SCYNEXIS Announces FDA Acceptance and Priority Review of New Drug Application for Oral Ibrexafungerp for the Treatment of Vaginal Yeast Infections
Published: 2020-12-07 (Crawled : 13:02) - globenewswire.com
SCYX | $1.47 3.52% 3.4% 80K
|
Health Technology
|
| O: 3.31%
H: 9.77%
C: 8.09%
fda drug fda acceptance new drug treatment injection infections
Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
Published: 2020-12-07 (Crawled : 13:00) - globenewswire.com
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: -2.91%
H: 0.0%
C: -7.0%
trial phase 3 phase 1 phase 2 clinical hold
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
Published: 2020-12-07 (Crawled : 13:00) - globenewswire.com
OPRX A | $9.35 -1.89% -1.93% 150K
|
Technology Services
|
| O: 1.97%
H: 1.62%
C: -2.31%
life science health
ALX Oncology Announces Updates on Planned ALX148 Phase 2 Head and Neck Cancer Studies
Published: 2020-12-07 (Crawled : 12:01) - globenewswire.com
ALXO | $15.72 -2.24% -2.29% 670K
|
Commercial Services
|
| O: -1.17%
H: 2.55%
C: -2.97%
cancer phase 2 agx148
Nabriva Therapeutics and Sinovant Sciences Restructure License Agreement for XENLETA for Community-Acquired Bacterial Pneumonia in China
Published: 2020-12-07 (Crawled : 12:01) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 4.05%
H: 3.38%
C: -1.82%
license china acquired
Celyad Oncology Provides Updates on Allogeneic and Autologous CAR T Programs at 62nd ASH Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 06:01) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -8.99%
H: 1.33%
C: -1.2%
car-t
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.